xml version="1.0" encoding="utf-8" ?   Form 8-K    

   CONDUENT Inc false 0001677703        0001677703   2022-01-04 2022-01-04      

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

FORM 8-K 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) 

of the Securities Exchange Act of 1934 

Date of Report (date of earliest event reported): January 4, 2022 

 CONDUENT INCORPORATED  

(Exact name of registrant as specified in its charter) 

  [DATA_TABLE_REMOVED] 

100 Campus Drive, Suite 200, 

Florham Park, New Jersey 

07932 

(Address of principal executive offices) (Zip Code) 

Registrant’s telephone number, including area code: (844) 663-2638 

Not Applicable 

(Former name or former address, if changed since last report) 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 

 ☐  

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

 ☐  

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

  [DATA_TABLE_REMOVED] 

  [DATA_TABLE_REMOVED] 

Securities registered pursuant to Section 12(b) of the Act: 

  [DATA_TABLE_REMOVED] 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

☐ Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

 Item 8.01.  

Other Events.  

On January 4, 2022, Conduent Incorporated issued a press release announcing that its wholly owned subsidiary, Conduent Business Services, LLC, entered into a definitive agreement to sell its Midas suite of patient safety, quality and advanced analytics solutions. The consummation of the transaction is subject to regulatory approval and the satisfaction or waiver of customary closing conditions, and is expected to close in the first quarter of 2022.  

A copy of the press release is attached as Exhibit 99.1 hereto. The information contained in Item 8.01 and in Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed “filed” with the Securities and Exchange Commission for purposes of Section 18 of the Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.  

 Item 9.01.  

Financial Statements and Exhibits.  

(d) Exhibits.  

  [DATA_TABLE_REMOVED]  

SIGNATURES  

Pursuant to the requirements of the Securities Exchange Act of 1934, Registrant has duly authorized this Report to be signed on its behalf by the undersigned duly authorized.  

Date: January 4, 2022  

 CONDUENT INCORPORATED 

 By:    

/s/ KEVIN CIAGLO 

Kevin Ciaglo 

Assistant Secretary